European Scientists Developing Alzheimer’s ‘Cure’? [Exclusive]

By Jack Taylor Posted January 4, 2022

For readers of Turapür Today, I’ve talked at length at the hope that one day there will be a viable cure for Alzheimer’s. 

And according to the ground-breaking work of scientists in Europe, this could be a reality during our lifetime.  

Today I want to share the exclusive details (and facts) about this potential Alzheimer’s ‘cure’. 

While this possibility is very exciting, I want to be realistic with you about this promising news… and why it should all be met with a bit of skepticism.  

Here’s everything you need to know… and what this all means if you have a history of Alzheimer’s in your family.  

According to findings recently published in the journal Molecular Psychiatry, British and German scientists suggest a vaccine for Alzheimer’s may one day be a reality.  

Researchers from Leicester University, the University Medical Center Göttingen, and the medical research charity LifeArc, have reported that studies and tests around this newly developed Alzheimer’s approach is showing serious promise – both as a concrete treatment for the disorder AND as a means of producing an effective vaccine. 

Yes, an Alzheimer’s vaccine is being studied. 

But, that’s as far as I’m going to go with this news (for now). 

While this news shows some promise, it should be noted that the research around a potential Alzheimer’s vaccine is still VERY early, and will require many more months (if not years) of research. 

I’m also presenting this news with skepticism because of two words… 

BIG PHARMA! 

Let’s face it. Big Pharma is already convinced they have their fingers on the pulse of an Alzheimer’s cure. And with the news of this potential vaccine out there, there’s no doubt they will do their best to pounce and accelerate the process.  

And if history is any indicator of Big Pharma’s role, we already know this is a potential recipe for disaster!  

Just look at what’s happened over the past few months… 

Last June, the U.S. Food and Drug Administration (FDA) approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease. This marked the first time the FDA has approved a new therapy for the disease since 2003. 

Aducanumab was developed for patients with mild cognitive impairment and is intended to slow progression of Alzheimer’s disease (not just ease symptoms). 

It turns out that under the terms of the FDA’S conditional approval, aducanumab’s developer and manufacturer – Biogen – has NINE years to determine if the drug even works! 

That’s right, folks… Big Pharma managed to score approval for a drug despite needing nearly a decade to prove that it’s actually effective. 

While at the same time, giving millions of innocent victims of Alzheimer’s false hope. 

But that doesn’t mean you need to be a victim of Big Pharma’s relentless greed.  

If you have a history of Alzheimer’s in your family, or believe you may be at risk, the single best thing you can do is to continue to have on-going conversations with your doctor on the treatment plan that’s right for you. 

After all, there’s no ‘one-size-fits-all’ approach to stopping Alzheimer’s… and there’s certainly no mainstream cure around the corner.